|
87
|
298
|
3ubdA |
Structure of n-terminal domain of rsk2 kinase in complex with flavonoid glycoside sl0101 |
|
100
|
255
|
3uv5A |
Crystal structure of the tandem bromodomains of human transcription initiation factor tfiid subunit 1 (taf1) |
|
81
|
266
|
3up2A |
Aurora a in complex with rpm1686 |
|
82
|
307
|
3uc4A |
The crystal structure of snf1-related kinase 2.6 |
|
258
|
949
|
3tl5A |
Discovery of gdc-0980: a potent, selective, and orally available class i phosphatidylinositol 3-kinase (pi3k)/mammalian target of rapamycin (mtor) kinase inhibitor for the treatment of cancer |
|
79
|
265
|
3u9nA |
X-ray crystal structure of compound 1 bound to human chk1 kinase domain |
|
250
|
950
|
3tjpA |
Crystal structure of pi3k gamma with n6-(3,4-dimethoxyphenyl)-2-morpholino-[4,5'-bipyrimidine]-2',6-diamine |
|
108
|
327
|
3u4uA |
Casein kinase 2 in complex with az-inhibitor |
|
67
|
276
|
3tv6A |
Human b-raf kinase domain in complex with a methoxypyrazolopyridinyl benzamide inhibitor |
|
79
|
279
|
3tkhA |
Crystal structure of chk1 in complex with inhibitor s01 |
|
114
|
396
|
3twjA |
Rho-associated protein kinase 1 (rock 1) in complex with rki1447 |
|
114
|
394
|
3tv7A |
Human rho-associated protein kinase 1 (rock 1) in complex with rki1342 |
|
124
|
437
|
3tpvB |
Structure of phipa bound to adp |
|
128
|
436
|
3tpdA |
Structure of phipa, monoclinic form |
|
84
|
279
|
3tkiA |
Crystal structure of chk1 in complex with inhibitor s25 |
|
129
|
436
|
3tpbA |
Structure of hipa(s150a) |
|
138
|
436
|
3tpeA |
The phipa p3121 structure |
|
270
|
949
|
3t8mA |
Rational design of pi3k-alpha inhibitors that exhibit selectivity over the pi3k-beta isoform |
|
73
|
276
|
3tv4A |
Human b-raf kinase domain in complex with an bromopyridine benzamide inhibitor |
|
132
|
436
|
3tptA |
Structure of hipa(d309q) bound to adp |
|
119
|
414
|
3tkuA |
Mrck beta in complex with fasudil |
|
92
|
304
|
3tl8A |
The avrptob-bak1 complex reveals two structurally similar kinaseinteracting domains in a single type iii effector |
|
30
|
167
|
3te5A |
Structure of the regulatory fragment of sacchromyces cerevisiae ampk in complex with nadh |
|
2
|
17
|
3teiB |
Crystal structure of human erk2 complexed with a mapk docking peptide |
|
0
|
14
|
3taxB |
A neutral diphosphate mimic crosslinks the active site of human o-glcnac transferase |
|
97
|
326
|
3tacA |
Crystal structure of the liprin-alpha/cask complex |
|
31
|
166
|
3tdhA |
Structure of the regulatory fragment of sccharomyces cerevisiae ampk in complex with amp |
|
83
|
274
|
3t9iA |
Pim1 complexed with a novel 3,6-disubstituted indole at 2.6 ang resolution |
|
29
|
166
|
3t4nA |
Structure of the regulatory fragment of saccharomyces cerevisiae ampk in complex with adp |
|
75
|
276
|
3skcA |
Human b-raf kinase in complex with an amide linked pyrazolopyridine inhibitor |
|
64
|
152
|
3si5A |
Kinetochore-bubr1 kinase complex |
|
107
|
350
|
3sd0A |
Identification of a glycogen synthase kinase-3b inhibitor that attenuates hyperactivity in clock mutant mice |
|
88
|
316
|
3sheA |
Novel atp-competitive mk2 inhibitors with potent biochemical and cell-based activity throughout the series |
|
112
|
418
|
3sdmA |
Structure of oligomeric kinase/rnase ire1 in complex with an oligonucleotide |
|
96
|
418
|
3sdjA |
Structure of rnase-inactive point mutant of oligomeric kinase/rnase ire1 |
|
77
|
287
|
3sc1A |
Novel isoquinolone pdk1 inhibitors discovered through fragment-based lead discovery |
|
251
|
949
|
3sd5A |
Crystal structure of pi3k gamma with 5-(2,4-dimorpholinopyrimidin-6-yl)-4-(trifluoromethyl)pyridin-2-amine |
|
104
|
350
|
3sayA |
Crystal structure of human glycogen synthase kinase 3 beta (gsk3b) in complex with inhibitor 142 |
|
261
|
945
|
3s2aA |
Crystal structure of pi3k-gamma in complex with a quinoline inhibitor |
|
94
|
310
|
3s95A |
Crystal structure of the human limk1 kinase domain in complex with staurosporine |
|
82
|
287
|
3rwpA |
Discovery of a novel, potent and selective inhibitor of 3-phosphoinositide dependent kinase (pdk1) |
|
145
|
491
|
3s1aB |
Crystal structure of the phosphorylation-site double mutant s431e/t432e of the kaic circadian clock protein |
|
84
|
288
|
3rwqA |
Discovery of a novel, potent and selective inhibitor of 3-phosphoinositide dependent kinase (pdk1) |
|
143
|
506
|
3s1aA |
Crystal structure of the phosphorylation-site double mutant s431e/t432e of the kaic circadian clock protein |
|
104
|
334
|
3rpsA |
Structure of human ck2alpha in complex with the atp-competitive inhibitor 3-(4,5,6,7-tetrabromo-1h-benzotriazol-1-yl)propan-1-ol |
|
77
|
290
|
3rnyA |
Crystal structure of human rsk1 c-terminal kinase domain |
|
269
|
949
|
3r7qA |
Structure-based design of thienobenzoxepin inhibitors of pi3- kinase |
|
23
|
159
|
5xlmA |
Monomer form of m.tuberculosis pkni sensor domain |
|
83
|
282
|
3rcjA |
Rapid preparation of triazolyl substituted nh-heterocyclic kinase inhibitors via one-pot sonogashira coupling tms-deprotection cuaac sequence |
|
84
|
256
|
3re4A |
Crystal structure of archaeoglobus fulgidus rio1 kinase bound to toyocamycin. |
